Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a223ae6b5fd1cb43

Jump to content

Cubilin

From Wikipedia, the free encyclopedia

CUBN
Identifiers
AliasesCUBN, IFCR, MGA1, gp280, cubilin, IGS, IGS1
External IDsOMIM: 602997; MGI: 1931256; HomoloGene: 37434; GeneCards: CUBN; OMA:CUBN - orthologs
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001081

NM_001081084

RefSeq (protein)

NP_001072

NP_001074553

Location (UCSC)Chr 10: 16.82 – 17.13 MbChr 2: 13.28 – 13.5 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Cubilin is a protein that in humans is encoded by the CUBN gene.[5][6][7] It is present upon the luminal surface of enterocytes of the ileum where it facilitates absorption of vitamin B12 by acting as a receptor for IF-cobalamin (intrinsic factor - vitamin B12) complexes, enabling endocytosis of complexes by means of amnionless (AMN).[8][9]

Biochemistry

[edit]

Cubilinis essentially only present in the small intestine and kidneys.[10]

A complex of amnionless and cubilin forms the cubam receptor.[11]

Clinical significance

[edit]

Mutations in CUBN may play a role in autosomal recessive megaloblastic anemia.[7]

Cubilin is a potential diagnostic and prognostic cancer biomarker for kidney cancer.[12] Based on patient survival data, high levels of cubilin in tumor cells is a favourable prognostic biomarker in renal cell carcinoma.[13][14]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000107611 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000026726 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Kozyraki R, Kristiansen M, Silahtaroglu A, Hansen C, Jacobsen C, Tommerup N, et al. (June 1998). "The human intrinsic factor-vitamin B12 receptor, cubilin: molecular characterization and chromosomal mapping of the gene to 10p within the autosomal recessive megaloblastic anemia (MGA1) region". Blood. 91 (10): 3593–3600. doi:10.1182/blood.V91.10.3593. PMID 9572993.
  6. Moestrup SK, Kozyraki R, Kristiansen M, Kaysen JH, Rasmussen HH, Brault D, et al. (March 1998). "The intrinsic factor-vitamin B12 receptor and target of teratogenic antibodies is a megalin-binding peripheral membrane protein with homology to developmental proteins". The Journal of Biological Chemistry. 273 (9): 5235–5242. doi:10.1074/jbc.273.9.5235. PMID 9478979.
  7. 1 2 "Entrez Gene: CUBN cubilin (intrinsic factor-cobalamin receptor)".
  8. Viola-Villegas N, Rabideau AE, Bartholomä M, Zubieta J, Doyle RP (August 2009). "Targeting the cubilin receptor through the vitamin B(12) uptake pathway: cytotoxicity and mechanistic insight through fluorescent Re(I) delivery". Journal of Medicinal Chemistry. 52 (16): 5253–5261. doi:10.1021/jm900777v. PMID 19627091.
  9. Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. (2022). Harrison's principles of internal medicine (21st ed.). New York: McGraw Hill. ISBN 978-1-264-26851-1.
  10. "Tissue expression of CUBN - Summary - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2017-09-06.
  11. Kozyraki R, Cases O (2013). "Cubilin, the intrinsic factor-vitamin B12 receptor". Biochimica et Biophysica Acta. 1832 (10): 1563–1568. doi:10.1016/j.bbadis.2013.05.012.
  12. Gremel G, Djureinovic D, Niinivirta M, Laird A, Ljungqvist O, Johannesson H, et al. (January 2017). "A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma". BMC Cancer. 17 (1) 9. doi:10.1186/s12885-016-3030-6. PMC 5215231. PMID 28052770.
  13. Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, et al. (August 2017). "A pathology atlas of the human cancer transcriptome". Science. 357 (6352) eaan2507. New York, N.Y. doi:10.1126/science.aan2507. PMID 28818916.
  14. "Expression of CUBN in renal cancer - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2017-09-06.

Further reading

[edit]
[edit]